# Vaccine Therapy and Ganciclovir in Treating Patients With Mesothelioma

> **NCT00006216** · PHASE1 · UNKNOWN · sponsor: **Louisiana State University Health Sciences Center in New Orleans**

## Conditions studied

- Malignant Mesothelioma

## Interventions

- **BIOLOGICAL:** PA-1-STK ovarian carcinoma vaccine
- **DRUG:** ganciclovir

## Key facts

- **NCT ID:** NCT00006216
- **Lead sponsor:** Louisiana State University Health Sciences Center in New Orleans
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 1997-08
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** — (—)
- **Last updated:** 2013-09-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00006216

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00006216, "Vaccine Therapy and Ganciclovir in Treating Patients With Mesothelioma". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT00006216. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*